Expression of the GLP-1 Receptor in Mouse, Rat, and Human Pancreas
Open Access
- 23 June 2008
- journal article
- research article
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 56 (9) , 841-851
- https://doi.org/10.1369/jhc.2008.951319
Abstract
We studied the intra-islet localization of the glucagon-like peptide 1 receptor (GLP-1R) by colocalization studies of the GLP-1R mRNA and protein with islet cell hormones in mice, rats, and humans. In contrast to previous reports, we show that the GLP-1R is selectively located on the β cells. The localization of GLP-1R in islets and ducts was studied using ISH and double and triple fluorescence microscopy. In normal pancreatic tissue from mice and rats, GLP-1R mRNA was only detectable in the β cells. Double and triple immunofluorescence using two different GLP-1R antisera and combinations of insulin, glucagon, pancreatic polypeptide, and somatostatin showed that GLP-1R protein is almost exclusively colocalized with insulin. The same pattern was observed in human pancreas, but the GLP-1R expression was more heterogeneous, with populations of insulin immunoreactive cells with high and low expression. This is the first time that the GLP-1R has been localized in human islets. Furthermore, GLP-1R immunoreactivity was found in the pancreatic ducts in mouse, rat, and human pancreas. As an important confirmation of the specificity of our methods, we found no signals for GLP-1R mRNA or protein in pancreatic tissue from gene-targeted GLP-1R—deficient mice. In conclusion, our data suggest that the GLP-1 receptor is restricted to the pancreatic β cells and the lack of receptor immunoreactivity on δ cells cannot be explained suitably to correspond with published in vivo and in vitro data. This manuscript contains online supplemental material at http://www.jhc.org . Please visit this article online to view these materials.Keywords
This publication has 50 references indexed in Scilit:
- Preservation of β-cell function by targeting β-cell massTrends in Pharmacological Sciences, 2008
- The Physiology of Glucagon-like Peptide 1Physiological Reviews, 2007
- Liraglutide: a once-daily GLP-1 analogue for the treatment of Type 2 diabetes mellitusExpert Opinion on Investigational Drugs, 2007
- The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetesPublished by Elsevier ,2006
- Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in miceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- Homologous and heterologous asynchronicity between identified α‐, β‐ and δ‐cells within intact islets of Langerhans in the mouseThe Journal of Physiology, 1999
- Point Mutations in the First and Third Intracellular Loops of the Glucagon-like Peptide-1 Receptor Alter Intracellular SignalingBiochemical and Biophysical Research Communications, 1996
- Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37)Nature, 1993
- Functional receptors for the insulinotropic hormone glucagon‐like peptide‐I(7–37) on a somatostatin secreting cell lineFEBS Letters, 1991
- Receptors for glucagon-like peptide-1(7–36) amide on rat insulinoma-derived cellsJournal of Endocrinology, 1988